Novo, Unicef Launch $18 Million Child Obesity Prevention Initiative

08:45 AM EDT, 09/22/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) is investing $18 million in an expanded four-year partnership with Unicef to prevent childhood overweight and obesity, according to a Tuesday release. The program, which builds on the parties' existing collaboration from 2019, runs from 2027 to 2030 and aims to reach 80 million children across Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya. The Danish drugmaker's funds will support evidence-based policies and obesity prevention services in the seven priority countries.